Certara-CMYK-01.jpg
Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
May 20, 2021 08:00 ET | Certara
PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, Chief Executive Officer, and Andrew Schemick,...
Certara-CMYK-01.jpg
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
May 13, 2021 08:00 ET | Certara
PRINCETON, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of new versions of its Immunogenicity (IG) and...
Certara-CMYK-01.jpg
Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance
May 06, 2021 16:15 ET | Certara
PRINCETON, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2021. ...
Certara-CMYK-01.jpg
Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier
May 04, 2021 18:15 ET | Certara
PRINCETON, N.J., May 04, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of its Secondary Intelligence™ software, the first and...